Akorn, Inc. (NASDAQ: AKRX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced multiple FDA approvals over the Good Friday/Easter holiday break. As you could imagine, the approvals led to excitement among investors who are pushing the stock on a run for the top. Today, … Read more
Akorn, Inc. (NASDAQ: AKRX) is having an overwhelmingly rough start to the trading session this morning as news is breaking that a merger agreement signed about a year ago is falling apart. That’s right, the company is no longer likely to merge with Fresenius Medical Care AG & Co. (ADR) (NYSE: FMS). While this is painful news … Read more
Akorn, Inc. (NASDAQ: AKRX) is having an overwhelmingly rough day in the market today, and for good reason. In the after-hours session last night, news started to break of an investigation surrounding the company. Unfortunately, this news led to fear, sending the stock spiraling downward. Today, we’ll talk about the investigation news, what we’re seeing from … Read more
Akorn, Inc. (NASDAQ: AKRX) was off to what seemed like it was going to be a rough day in the market today. However, that all changed minutes ago as reports came out that the company was nearing a deal to be taken over. Of course, this led to excitement among investors who pushed the stock … Read more
Akorn, Inc. (NASDAQ: AKRX) Akorn is having an incredibly strong start to the trading session today, and for good reason. The company has confirmed that it is in talks regarding a potential merger. Of course, this led to investor excitement, sending the stock skyward and prompting our partners at Trade Ideas to alert us to … Read more